Publication Name	World Journal of Hepatology
Manuscript ID	16356
Country	United Kingdom

Received	2015-01-14 14:36
Peer-Review Started	2015-01-15 22:45
To Make the First Decision	2015-01-20 13:40
Return for Revision	2015-01-23 09:54
Revised	2015-01-26 00:00
Second Decision	2015-03-05 10:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-03-09 17:36
Articles in Press	2015-03-09 17:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-04-23 10:55
Publish the Manuscript Online	2015-05-13 10:06

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies
Manuscript Source	Invited Manuscript
All Author List	Juan Acevedo
Funding Agency and Grant Number
Corresponding Author	Juan Acevedo, MD, PhD, Department of Gastroenterology and Hepatology, Queen Alexandra Hospital, Southwick Hill Road, PO6 3LY Portsmouth, United Kingdom. juan.acevedo@porthosp.nhs.uk
Key Words	Bacterial infections; Multiresistant bacteria; Antibiotic; Liver cirrhosis
Core Tip	There is a growing prevalence of multiresistant bacteria in nosocomial and in health-care associated settings worldwide. Nowadays, it is necessary that all liver units assess the presence of antibiotic resistance in their population. The classical empirical antibiotic therapy, third generation cephalosporins, can no longer be employed in areas with high prevalence of multire-sistant bacterial infections. The current editorial focuses on the different patterns of resistance across countries and on its therapeutic implications.
Publish Date	2015-05-13 10:06
Citation	Acevedo J. Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies. World J Hepatol 2015; 7(7): 916-921
URL	http://www.wjgnet.com/1948-5182/full/v7/i7/916.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i7.916

Full Article (PDF)	WJH-7-916.pdf
Full Article (Word)	WJH-7-916.doc
Manuscript File	16356-Review.doc
Answering Reviewers	16356-Answering reviewers.pdf
Audio Core Tip	16356-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	16356-Conflict-of-interest statement.pdf
Copyright License Agreement	16356-Copyright assignment.pdf
Peer-review Report	16356-Peer-review(s).pdf
Scientific Misconduct Check	16356-Scientific misconduct check.pdf
Scientific Editor Work List	16356-Scientific editor work list.pdf